ArticleThoracic cancer2018

Combination therapy of apatinib with icotinib for primary acquired icotinib resistance in patients with advanced pulmonary adenocarcinoma with EGFR mutation.

Pinghui Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.